non-dihydropyridine calcium channel antagonists in rate control in atrial fibrillation (AF)
Last reviewed 05/2021
Non-dihydropyridine calcium channel antagonists in control of rate in atrial fibrillation (1)
| Usual oral maintenance dose | |
| verapamil | 40 mg b.i.d. to 360 mg (ER) o.d. |
| diltiazem | 60 mg t.i.d. to 360 mg (ER) o.d. |
ER = extended release formulations
Reference:
- (1) Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. European Heart Journal (2010) 31, 2369-2429.